Company news

Sana Biotechnology, Inc. news in 2025

Sana Biotechnology, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

December 7, 2025

Sana Biotechnology to Present at December 2025 Investor Conferences

November 23, 2025

Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates

November 5, 2025

Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit

November 3, 2025

Yellowstone Biosciences Appoints James ("Jim") MacDonald as Chief Executive Officer

September 16, 2025

Sana Biotechnology to Present at September 2025 Investor Conferences

August 25, 2025

Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares

August 19, 2025

eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors

August 19, 2025

Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates

August 10, 2025

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

August 5, 2025

Sana Biotechnology Announces Pricing of Public Offering

August 5, 2025

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

August 3, 2025

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

June 22, 2025

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

June 8, 2025

Sana Biotechnology to Present at June 2025 Investor Conferences

May 27, 2025

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 11, 2025

Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates

May 7, 2025

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

March 16, 2025

Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference

February 23, 2025

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 7, 2025

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

January 6, 2025

Decks in 2025